A Phase 3 Randomized Multicenter Study of Cetuximab, Oxaliplatin, 5-Fluorouracil, and Leucovorin vs. Oxaliplatin, 5-Fluorouracil, and Leucovorin in Subjects With Previously Treated Metastatic, EGFR-Positive Colorectal Carcinoma.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Carcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms EXPLORE
- Sponsors ImClone Systems
- 25 Aug 2009 Additional lead trial investigator Pendergrass K identified as reported by ClinicalTrials.gov.
- 25 Aug 2009 Additional lead trial investigator Pendergrass K identified as reported by ClinicalTrials.gov.
- 08 Jan 2008 Status changed from in progress to completed.